Monday 20th January 2025, 3:00pm
Dyneval, the pioneering fertility technology company, has raised £515,772 in a new round of investment to advance its flagship product, the Dynescan. The funding round included funding from angel investment connector Lifted Ventures. This funding will enable the company to leverage an additional £85,000 grant funding from Scottish Enterprise to develop a high-throughput version of the Dynescan, capable of analysing four samples in parallel.
The Dynescan is the first semen analyser capable of measuring semen quality over time under conditions that replicate the reproductive tract.
This unique technology provides data directly correlated with fertility rates, already transforming fertility analysis for veterinary applications and holding promise for human fertility research.
Since entering the veterinary market in 2022, Dyneval has rapidly gained traction, attracting 31 customers across 11 countries, including dairy genetics companies, farm veterinarians, bovine IVF laboratories, and a multinational dairy company.
“This funding represents a pivotal moment for Dyneval. By expanding the capabilities of the Dynescan, we’re enabling experts to gain precise insights that improve reproductive outcomes for livestock, with transformative potential for human fertility research.”
Dr Tiffany Wood, CEO, DynevalWith male fertility declining by 62% over the past 50 years, tools like the Dynescan are critical for understanding and addressing the factors influencing fertility. Dyneval is proving our commitment to providing precise, user-independent technology that bridges the gap between research and practical application.
Trials conducted in the UK and Argentina have shown that semen maintaining motility for over two hours leads to conception rates 8 – 10% higher. The new funding will accelerate the development of a high-throughput version of the Dynescan, making fertility analysis more efficient and accessible to customers.
“Dyneval is addressing a significant gap in fertility technology. The Dynescan’s ability to measure semen quality over time in real-world conditions is a game-changer, particularly as it directly correlates with improved conception rates. We are proud to back and support talented female founders like Dr Tiffany Wood, whose vision and leadership are paving the way for innovation in sectors that directly impact global food security and human health. This investment will help scale their innovation and enhance their impact across the agricultural and human health sectors.”
Jordan Dargue, Co-founder, Lifted VenturesExpressions of interest in the Dynescan or collaboration opportunities can be directed to contact@dyneval.com.
Article source: Lifted Ventures
Roslin Innovation Centre
The University of Edinburgh
Easter Bush Campus
Midlothian EH25 9RG
